Buzzy “Highly Recommended” In National Injection Guidelines
Non-adherence is a significant problem in medical management. New national guidelines recommend Buzzy Pain Relief.
Non-adherence is a significant problem in medical management. New national guidelines recommend Buzzy Pain Relief.
We have been broadening our base of pain relief therapeutics to incorporate improved blood flow and venous access, based on research showing our Buzzy® device improves phlebotomy success
Atlanta, GA – MMJ Labs LLC, the world leader in non-invasive reusable pain relief devices, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)
© 2016-2021 Pain Care Labs, All rights reserved. Powered by Blacksmith Digital
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.